Document Detail

Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: evidence of a protective effect of beta-blocking antianginal medications.
MedLine Citation:
PMID:  10399999     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The purpose of this study was to determine whether antianginal medications modify the prognostic significance of exercise single photon emission computed tomography (SPECT) ischemia. BACKGROUND: Antianginal medications (especially beta-adrenergic blocking agents) limit exercise SPECT ischemia, but it is not known whether such medications also modify the prognostic effect of exercise SPECT ischemia. METHODS: We included 352 patients with coronary heart disease, who had exercise Tl-201 SPECT and coronary angiography, and who were initially treated medically. Survival Cox models were applied in patients for whom classes of antianginal medications taken at exercise SPECT were the same as those prescribed for follow-up (GI; n = 136), and in patients for whom new classes of antianginal medications, including beta-blockers (GII; n = 79) or not including beta-blockers (GIII; n = 113), were added for follow-up. RESULTS: During a mean 5.3+/-1.6 years of follow-up, 45 patients had cardiac death or myocardial infarction. Variables reflecting necrosis (irreversible defect extent, left ventricular ejection fraction) and those from coronary angiography provided equivalent prognostic information in the three groups. In contrast, the SPECT variable reflecting ischemia (reversible defect extent), which provided comparable prognostic information in GI (p = 0.005) and GIII (p = 0.004), lost its prognostic significance (p = 0.54) in GII, and was associated with a lower relative risk in GII than in GI or GIII (both p < 0.05). CONCLUSIONS: In patients with coronary heart disease, the introduction of antianginal medications, when including beta-blockers, appears to have a favorable effect on the deleterious prognostic effect of exercise ischemia.
P Y Marie; N Danchin; F Branly; M Angioï; A Grentzinger; J M Virion; B Brouant; P Olivier; G Karcher; Y Juillière; F Zannad; A Bertrand
Related Documents :
7970439 - Pharmacological cardiac stress: when and how?
3264019 - Normal spect thallium-201 bull's-eye display: gender differences.
10399999 - Effects of medical therapy on outcome assessment using exercise thallium-201 single pho...
18242479 - Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessm...
3587799 - Improvement in indices of myocardial ischaemia in a case of hypertrophic obstructive ca...
6869289 - Abnormal thallium-201 scans in patients with chest pain and angiographically normal cor...
24969269 - Effects of underwater treadmill training on leg strength, balance, and walking performa...
14997099 - Initial evaluation of a shoulder arthroscopy simulator: establishing construct validity.
8496479 - Closest speaking space during the production of sibilant sounds and its value in establ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  34     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-07-30     Completed Date:  1999-07-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  113-21     Citation Subset:  AIM; IM    
Department of Nuclear Medicine, UPRES EA 2403, CHU Nancy, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Calcium Channel Blockers / therapeutic use
Exercise Test
Middle Aged
Molsidomine / therapeutic use
Myocardial Ischemia / drug therapy*,  radionuclide imaging*
Nitrates / therapeutic use
Regression Analysis
Retrospective Studies
Thallium Radioisotopes / diagnostic use*
Tomography, Emission-Computed, Single-Photon*
Treatment Outcome
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 0/Nitrates; 0/Thallium Radioisotopes; 0/Vasodilator Agents; 25717-80-0/Molsidomine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrati...
Next Document:  Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a noninvasive, rapid an...